I am sorry to hear that. Investing in pre revenue companies is certainly risky and the #1 best way to mitigate the risk is to look at the management.#2 look at the science and the likelihood of success through trials. #3 is analyze the share structure and look at the way the company has used available shares. Ignore traders as most are not intelligent enough to understand we do not need USA and frankly not part of our game plan until we legalize. Europe and Canada alone will propel us to incredible heights. I have uncomfortable feeling until the lawsuit in New York is wrapped up we may continue to experience obvious manipulation. Hopefully you can hang in there because you have been a reliable long.